| Microorganism |
|
|
|
| Antimicrobial |
 |
|
Reference |
| Rhodococcus equi (macrolide-susceptible) |
0.06 |
0.12 |
≤0.06 － 0.12 |
Clarithromycin (Biaxin) |
1042 |
| Rhodococcus equi (macrolide-susceptible) |
0.5 |
0.5 |
0.12 － 1 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
1042 |
| Rhodococcus equi (macrolide-susceptible) |
0.5 |
0.5 |
≤0.25 － 1 |
Vancomycin (Vancocyn, Lyphocin) |
1042 |
| Rhodococcus equi (macrolide-susceptible) |
≤0.5 |
≤0.5 |
≤0.5 － >8 |
Rifampicin (Rifampin) |
1042 |
| Rhodococcus equi (macrolide-susceptible) |
0.5 |
1 |
≤0.25 － 2 |
Gentamicin (Gentamycin, Garamycin) |
1042 |
| Rhodococcus equi (macrolide-susceptible) |
1 |
1 |
0.25 － 2 |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
1042 |
| Rhodococcus equi (macrolide-susceptible) |
1 |
1 |
0.5 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
1042 |
| Rhodococcus equi (macrolide-susceptible) |
1 |
2 |
≤0.06 － 2 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
1042 |
| Rhodococcus equi (macrolide-susceptible) |
2 |
2 |
≤0.5 － >4 |
Enrofloxacin |
1042 |
| Rhodococcus equi (macrolide-susceptible) |
>4 |
>8 |
≤0.25 － >8 |
Ceftiofur |
1042 |
| Rhodococcus equi (macrolide-susceptible) |
8 |
16 |
4 － 32 |
Chloramphenicol (Chloromycetin) |
1042 |
| Rhodococcus equi (macrolide-susceptible) |
>16 |
>16 |
2 － >16 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
1042 |
| Rhodococcus equi (macrolide-susceptible) |
32 |
64 |
≤4 － >64 |
Tilmicosin |
1042 |
| Rhodococcus equi (macrolide-susceptible) |
>64 |
>64 |
32 － >64 |
Tulathromycin |
1042 |